July 31, 2026 – Sichuan GOWELL Pharmaceutical Co., Ltd. ("GOWELL Pharmaceutical"), the core manufacturing base of the GOWELL Group (Chengdu GOWELL) , has officially become a registered member of the Global Organization for EPA and DHA Omega-3s (GOED). The relevant information has been simultaneously included in the GOED official member directory (goedomega3.com/members/member/sichuan-gowell-pharmaceutical-co-ltd). This represents another significant milestone for GOWELL Pharmaceutical's high-purity fish oil in terms of international compliance and industry recognition, marking the company's official entry into the global Omega-3 industry chain compliance landscape and further strengthening its international registration footprint.

△ GOED Certificate of Membership

△ GOWELL Pharmaceutical in the GOED Official Member Directory

GOED: The Quality Gatekeeper and Scientific Authority of the Global Omega-3 Industry

GOED is one of the most influential international industry organizations in the global EPA and DHA Omega-3 sector. Established in 2006 and headquartered in the United States, GOED brings together member companies from multiple countries and regions covering all segments of the industry chain, including fisheries, crude oil suppliers, refiners, concentrators, brand owners, and contract manufacturers. GOED's mission is to "advance science and increase consumption of quality EPA and DHA Omega-3s worldwide," and it has long fulfilled three core industry functions: first, maintaining industry quality benchmarks – the GOED Monograph is one of the most widely adopted voluntary quality reference standards in the Omega-3 industry; second, advocating on behalf of the industry to governments and regulatory bodies worldwide, providing scientific input and data on regulations, scientific evidence, and nutrition/health claims; and third, publishing and maintaining EPA/DHA clinical research resources and industry/market data.

GOED membership requires applicant companies to submit applications and commitment documents in accordance with GOED membership rules and to comply with its Monograph and Code of Conduct. This credential may serve as an important reference factor for some brand owners and purchasers when evaluating suppliers' industry engagement, quality commitment, and compliance awareness, and may carry positive reference value in the supplier evaluation processes of certain international customers.

With this membership, GOWELL Pharmaceutical has officially become a member of this internationally authoritative industry organization. As a member company, GOWELL will conduct its relevant product and business activities in accordance with the GOED Monograph and Member Code of Conduct, and can directly issue membership credentials to global partners. This signifies that GOWELL Pharmaceutical's high-purity fish oil quality management and compliance systems have gained recognition from an international industry body, and represents a significant step in the company's deep integration into the global Omega-3 industry chain.

Joining GOED: A Further Step in GOWELL's Globalization Journey

As a pharmaceutical company with nearly two decades of deep engagement in the high-purity fish oil sector, GOWELL Pharmaceutical's official membership in GOED signifies deeper participation in international industry standards, smoother access pathways for international customers, and a systematic enhancement of international recognition for Chinese ω-3 raw materials.

First, upgrading global industry influence.** GOED is a widely influential industry organization in the global EPA and DHA Omega-3 field, with member companies covering major European and American raw material suppliers, brand owners, and formulation customers. Following its membership, GOWELL Pharmaceutical will have the opportunity to participate in relevant working groups, industry exchanges, and public policy advocacy activities, enhancing its opportunity and influence in engaging with industry standards and quality-related discussions.

Second, facilitating international customer access and supplier evaluation.** Many European and American nutrition product, dietary supplement, medical food, and infant formula brands that evaluate upstream Omega-3 raw material suppliers may consider GOED membership, compliance with the GOED Monograph, or related quality documentation as part of their supplier evaluation criteria. With its GOED registered membership, GOWELL Pharmaceutical can directly present its GOED credentials as a communication tool during customer audits, pre-qualification, and approved vendor list (AVL) maintenance.

Third, elevating the international brand trust of Chinese ω-3 products.** GOED membership carries a strong symbolic attribute of commitment to the organization's membership standards, quality principles, and integrity requirements – member companies must commit in writing to adhere to the GOED Monograph, Code of Conduct, and applicable policies. Using its GOED membership as a strategic anchor, GOWELL Pharmaceutical will systematically demonstrate to global customers the comprehensive strengths of Chinese ω-3 raw materials in terms of quality, ethics, and sustainability, helping to enhance the international recognition and brand image of Chinese Omega-3 raw materials.

Aligning with International Standards: GOWELL's Four-Tiered ω-3 Raw Material Capabilities and GOED Compliance Strength

1. Full-Form ω-3 Raw Material Supply Capability

GOWELL Pharmaceutical has established a high-purity ω-3 raw material platform covering four major chemical forms – triglycerides (TG), ethyl esters (EE), re-esterified triglycerides (rTG), and free fatty acids (FFA). EPA purity reaches up to 99%, DHA purity up to 99%, and total EPA+DHA content up to 95%, capable of providing compliant raw material support across three major sectors: nutritional products, API pharmaceuticals, and injectable-grade medicinal lipids.

2. Full-Dosage-Form Finished Product Capability

Beyond APIs, GOWELL Pharmaceutical has simultaneously developed finished dosage forms including soft capsules and fat emulsion injections, offering contract development and manufacturing (CDMO) services to global brand owners from raw materials to finished products, covering dietary supplements, nutritional products, APIs, and prescription formulations.

3. Multi-Source Sustainable Supply Chain

Raw material sources cover both fish and algae – the two mainstream ω-3 resources – allowing flexible matching of raw material pathways for different application scenarios (vegan nutrition, maternal and infant formula, sustainable seafood, clinical nutrition), aligning with GOED's and Western customers' ethical requirements for "responsible sourcing" and "traceable supply chains."

4. Full-Industry-Chain Compliance Registration Footprint

GOWELL Pharmaceutical's ω-3 product series has obtained regulatory registrations and certifications in multiple countries including China, the United States, the European Union, and South Korea: Omega-3 Ethyl Esters 90 has obtained EU CEP (No. CEP 2022-488-Rev 00), US DMF (MF041937), and Korea KDMF (수 323-5-ND); Icosapent Ethyl has obtained US DMF (MF043834) and Korea KDMF (20260415-211-J-2159); Fish Oil (28% ω-3 acids) and Olive Oil, Refined are simultaneously advancing through EU CEP technical review. This GOED membership adds another international industry organization credential to the company's global compliance system, bringing its international registration footprint closer to full completeness.

Building Independent Voice for China's High-End ω-3 Industry on the Global Compliance Stage

This official membership in GOED marks a new starting point for GOWELL Pharmaceutical's globalization strategy. Using its GOED membership as a strategic anchor, the company will deeply engage in global ω-3 industry scientific advocacy and quality standards development, leveraging GOWELL's core strengths to deliver compliant ω-3 raw materials and CDMO solutions from China to global customers in nutrition products, dietary supplements, medical foods, infant formula, and prescription drugs.

Through years of sustained scientific research, GOWELL Pharmaceutical has achieved independent technological breakthroughs and industrialization in high-purity ω-3 fatty acids and high-end injectable medicinal lipids, making it one of the first domestic manufacturers to achieve an integrated "oral-to-injectable" ω-3 lipid raw material and formulation portfolio.

GOWELL Pharmaceutical has also built a comprehensive product matrix in this field covering generic injectables, oral prescription drugs, and health foods: Omega-3 Fish Oil Fat Emulsion Injection (Liyouwei®) received marketing approval in 2023; Long-Chain Fat Emulsion Injection (OO) (Linapu®) received approval in 2024; high-purity ω-3 prescription drug Omega-3 Fatty Acid Ethyl Esters 90 Soft Capsules (Lilexin®) received approval in 2021; Icosapent Ethyl Soft Capsules (Liruixin®) received approval in 2023; and the high-purity fish oil health food product (Ou Cuien® Fish Oil Soft Capsules) received its initial national registration approval in 2014.

This GOED membership represents another significant step for GOWELL Pharmaceutical in exporting "China Quality" to the global high-end ω-3 API and nutrition product markets, marking the official entry of Chinese high-end ω-3 products into the membership system of a global Omega-3 industry organization. With this membership as a new starting point, GOWELL Pharmaceutical looks forward to collaborating with domestic and international partners to jointly advance the scientific progress and industrial upgrading of the global ω-3 industry.

GOWELL Food-Grade Fish Oil Raw Material Product List

GOWELL's food-grade fish oil raw materials mainly include high-purity EPA/DHA series, high-purity EPA series, and high-purity DHA series, as detailed below:

High-Purity EPA/DHA Series (EPA+DHA: 70-99%)

| Product Code| EPA | DHA |

| Gowell 5436 | 54% | 36% |

| Gowell 5040 | 50% | 40% |

| Gowell 6027 | 60% | 27% |

| Gowell 6025 | 60% | 25% |

| Gowell 5025 | 50% | 25% |

| Gowell 4832 | 48% | 32% |

High-Purity EPA (80%-99%)

| Product Code | Purity |

| Gowell E97 | 97% |

| Gowell E95 | 95% |

| Gowell E90 | 90% |

| Gowell E80 | 80% |

High-Purity DHA (80%-99%)

| Product Code| Purity |

| Gowell D97 | 97% |

| Gowell D95 | 95% |

| Gowell D90 | 90% |

| Gowell D80 | 80% |

In addition to the above products, all specifications can be customized according to customer requirements.

△ GOWELL Pharmaceutical Food-Grade Fish Oil Raw Material Product List

About the GOWELL Group

Sichuan GOWELL Pharmaceutical Co., Ltd. is the core manufacturing entity under the GOWELL Group (Chengdu GOWELL). Founded in 2005 and headquartered in the Chengdu High-Tech Zone, the Group is a professional, innovation-driven pharmaceutical group integrating drug R&D, manufacturing, and sales. The Group includes subsidiaries such as Sichuan GOWELL Pharmaceutical Co., Ltd., Shanghai Ou Cuien Biotechnology Co., Ltd., and Chengdu Zhengkang Pharmaceutical Co., Ltd., with over 800 employees.

GOWELL has established three major R&D technology platforms covering generics, innovative drugs, and fish oil. Core R&D team members have been recognized under prestigious talent programs including the Tianfu Qingcheng Plan, Tianfu Emei Plan, and Rongpiao Plan. From 2017 to 2025, cumulative R&D investment exceeded RMB 700 million, fueling sustained innovation.

In terms of patent portfolio, the company has filed a total of 123 patent applications, with 43 granted, including 33 invention patents, and has registered 185 trademarks.

△ GOWELL Pharmaceutical

△ GOWELL Pharmaceutical — Meishan, Sichuan GMP API Manufacturing Base

Business Inquiries and Technical Support

For samples, Certificates of Analysis (COA), technical documentation, registration standards, commercial quotations, or to request remote or on-site quality audit support for GOWELL Pharmaceutical's ω-3 series APIs, nutritional products, and API products, please contact Sichuan GOWELL Pharmaceutical Co., Ltd.

 △ For more product details or to request a technical information package, please contact the GOWELL sales team. We will match you with the corresponding product specifications and supply solutions as quickly as possible.

This document is intended for industry exchange and technical reference only and does not constitute a commercial offer or product commitment. Product specifications are subject to the final contract and COA.